Heart Attack Clinical Trials

Find Heart Attack Clinical Trials Near You

Norwegian Spontaneous Coronary Artery Dissection Study (NOR-SCAD Study)

Status: Recruiting
Location: See all (3) locations...
Study Type: Observational
SUMMARY

The Norwegian Spontaneous Coronary Artery Dissection Study (NOR-SCAD) is a national, multicenter prospective observational study conducted at major hospitals in Norway. The study investigates risk factors and complications of spontaneous coronary artery dissection (SCAD). Patients aged 18 years or older who are hospitalized with SCAD are recruited during the index hospitalization. Each participant will be followed for 52 weeks with scheduled visits at 8 and 12 weeks and a final phone call at 52 weeks. Evaluations include coronary CT angiography (CTA), cardiac assessments, genetic analyses, blood sampling, structured questionnaires, and a cardiopulmonary exercise test (CPET).

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Spontaneous coronary artery dissection

Locations
Other Locations
Norway
Haukeland University Hospital
RECRUITING
Bergen
Akershus University Hospital
RECRUITING
Oslo
Rikshospitalet, Oslo University Hospital
RECRUITING
Oslo
Contact Information
Primary
Anna Louise Astad Sørlie, MD
anloso@ous-hf.no
+47 926 55 483
Time Frame
Start Date: 2025-04-01
Estimated Completion Date: 2035-12-31
Participants
Target number of participants: 300
Treatments
Prospective
SCAD
Sponsors
Collaborators: St. Olavs Hospital, Ullevaal University Hospital, Universitetssykehuset i Nord-Norge HF, Helse Stavanger HF, University Hospital, Akershus, Haukeland University Hospital, Bergen, Norway, Sorlandet Hospital HF
Leads: Oslo University Hospital

This content was sourced from clinicaltrials.gov